OMER vs ORKA Stock Comparison

ORKA currently leads OMER in this stock comparison, with AIQ scores of 77 vs 64. The clearest difference is quality.

Market data as of Nov 15, 2026 market close· AIQ score gap 13 points
OMER
Healthcare
vs
ORKA
Healthcare
OMER
Omeros Corporation
Price
$17.49
Day move
-2.78%
AIQ Score
64/100
Best edge
Balanced
Sector
Healthcare
ORKA
Oruka Therapeutics, Inc.
Leads
Price
$105
Day move
+0.34%
AIQ Score
77/100
Best edge
Quality
Sector
Healthcare

What is the main difference between OMER and ORKA?

ORKA leads the current stock comparison as Oruka Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Omeros Corporation vs Oruka Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 8/10

ORKA leads

ORKA leads by 13 AIQ points, primarily on Quality and Risk Resilience, and the lead has widened from 2 points over 30 sessions. Wall Street currently favors OMER on target upside.

Stable: 4 of 5 evidence groups support ORKA, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 5Comparison trend: Strengthening
OMER

Omeros Corporation

AIQ Score
64/100
AIQ Edge Score
7/10
ORKA

Oruka Therapeutics, Inc.

Leads
AIQ Score
77/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors ORKA over OMER, 77 versus 64 as of Nov 15, 2026. ORKA's advantage is driven primarily by stronger quality and risk resilience. ORKA also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors OMER. 4 of 5 covered evidence groups favor ORKA today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. ORKA lead: Strengthening — the AIQ differential moved from 2 to 13 points over 30 sessions.

Compare Omeros Corporation and Oruka Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

OMER
+340.6%
ORKA
+313.1%

Total return comparison

Growth of $10,000, distributions reinvested

OMER $44,055 · ORKA $41,314

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare OMER and ORKA against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

OMER advantage
0
ORKA advantage
  • Quality55 vs 83
    ORKA +28
  • Risk Resilience33 vs 53
    ORKA +20
  • Momentum79 vs 81
    Even

4 of 5 evidence groups favor ORKA. ORKA’s edge is concentrated in quality and risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

OMER0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.76x)
  • RSI Midline Rejection — bearish, momentum, short horizon
ORKA+1 AIQ

Largest factor move: Momentum +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)

ORKA's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — OMER and ORKA both carry a full feed there.

The central trade-off

ORKA (Oruka Therapeutics, Inc.): the stronger current systematic profile, led by quality and risk resilience.

OMER (Omeros Corporation): the counter-case, on analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ORKA

ORKA on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

OMER

OMER on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

Even

The two are level on Momentum.

Lower downside

ORKA

ORKA on Risk Resilience, by 20 points.

Analyst upside

OMER

OMER on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ORKA, analyst targets favor OMER. That disagreement is the most useful thing on this page.

MeasureOMERORKANote
Implied upside to target+25.8%+9.2%OMER has more room
Target dispersion0%+13%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering313Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 5 covered evidence groups favor ORKA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreORKA64 vs 77
FundamentalsORKAEPS growth -76.9% vs 4.5%; TTM ROE -25.8% vs -4.2%
ValuationNot coveredNot covered
TechnicalsORKAPrice vs 50-day -4.3% vs 17.5%; vs 200-day 27% vs 45%
Risk ResilienceORKARisk Resilience 33 vs 53
Analyst expectationsOMERTarget upside 25.8% vs 9.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of OMER and ORKA and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 13 points. (supports the conclusion holding)
  • 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ORKA.

How the comparison changed

45 daily snapshots · Sep 14 – Nov 13

ORKA lead: Strengthening — the AIQ differential moved from 2 to 13 points over 30 sessions.

Sep 14OMER leads above the line · ORKA leads belowNov 13
Today
ORKA +13
64 vs 77
7 sessions ago
ORKA +11
65 vs 76
30 sessions ago
ORKA +2
66 vs 68
90 sessions ago
Not covered

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

OMERConflicted

1 bullish / 3 bearish / 2 neutral, conflicted

Only OMER

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • RSI Midline Rejection — bearish, momentum, short horizon
ORKAConflicted

4 bullish / 1 bearish / 1 neutral, conflicted

Only ORKA

  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Low Volume Rally Warning.

ORKA leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

OMERNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.78%, AIQ 0 points).

ORKAConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.34%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1OMER closes the Quality gap — currently 28 points behind, the largest single contributor to ORKA's edge.
  2. 2OMER's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3ORKA's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ORKA leads on balance
MetricOMERORKA
Revenue growth (YoY)188.4%0%
EPS growth (YoY)-76.9%4.5%
Gross margin95.8%0%
Operating margin-189.5%0%
Return on equity (TTM)-25.8%-4.2%
Debt to equity-1.630

Performance

ORKA leads 4 of 6 windows
MetricOMERORKA
1 week (5 sessions)3.4%2.4%
1 month (20 sessions)8%46.5%
3 months (63 sessions)0.7%-6.5%
6 months (126 sessions)42.8%70.1%
Year to date1.8%247.6%
1 year (252 sessions)153.8%272.3%

Technicals

ORKA has the stronger structure
MetricOMERORKA
RSI (14)47.964.4
ADX (14)12.235.2
Price vs 50-day-4.3%17.5%
Price vs 200-day27%45%
Volatility (1M, annualized)54.9%64.3%

Risk

ORKA is the more resilient
MetricOMERORKA
Beta1.61.4
Sharpe ratio1.362.29
Sortino ratio3.044.3
Max drawdown-49.5%-36.4%
Current drawdown-16.9%-6.8%
Annualized volatility110.8%69.1%
Value at risk (95%)-6.7%-5.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, OMER or ORKA?

On the Algovestiq AIQ Score, ORKA is the stronger of the two as of Nov 15, 2026, scoring 77 against OMER's 64. The edge comes from quality and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is OMER or ORKA the better buy right now?

ORKA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor ORKA over OMER?

The composite weights Quality, Value, Momentum and Risk Resilience. ORKA leads Quality by 28 points; ORKA leads Risk Resilience by 20 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, OMER or ORKA?

Analyst price targets imply +25.8% upside for OMER and +9.2% for ORKA, so the Street currently favors OMER. That points the opposite way to the AIQ Score, which favors ORKA. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, OMER or ORKA?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, OMER or ORKA?

OMER on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, OMER or ORKA?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, OMER or ORKA?

ORKA is the more resilient of the two, so the other name carries the higher downside risk. ORKA on Risk Resilience, by 20 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is OMER more profitable than ORKA?

ORKA leads on the comparable margin measures — gross margin 95.8% vs 0%; operating margin -189.5% vs 0%; ttm roe -25.8% vs -4.2%.

Is ORKA's lead over OMER getting stronger or weaker?

ORKA lead: Strengthening — the AIQ differential moved from 2 to 13 points over 30 sessions. This is measured from 45 daily comparison snapshots between 2026-09-14 and 2026-11-13. The lead has not changed hands in that window.

What would change the OMER vs ORKA verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: OMER closes the Quality gap — currently 28 points behind, the largest single contributor to ORKA's edge; OMER's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; ORKA's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about OMER and ORKA?

OMER: 1 bullish / 3 bearish / 2 neutral, conflicted. ORKA: 4 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on OMER is Golden Cross Active (bullish, long horizon). On ORKA it is Golden Cross Active (bullish, long horizon).

Compare OMER and ORKA with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.